Social Media and Pharmacovigilance 📱💊 All news

March 31, 2026

Social Media and Pharmacovigilance 📱💊

In the digital age, social media has become an essential tool for healthcare professionals and…

Saad

Love0

World Tuberculosis Day : a major public health and pharmacovigilance challenge All news

March 24, 2026

World Tuberculosis Day : a major public health and pharmacovigilance challenge

🌍 World Tuberculosis Day : a major public health and pharmacovigilance challenge   🦠 Tuberculosis…

Saad

Love0

NDSG Workplan 2026-2028: Data and AI in medicines regulation All news

March 23, 2026

NDSG Workplan 2026-2028: Data and AI in medicines regulation

Following the first workplan adopted in March 2025, the joint HMA/ EMA Network Data Steering…

Saad

Love0

Discover Pharmya – Your Partner in Pharmacovigilance All news

March 18, 2026

Discover Pharmya – Your Partner in Pharmacovigilance

Ensuring drug safety and regulatory compliance is essential in today’s healthcare landscape. At Pharmya, we…

Saad

Love0

EU implementation strategy of ICH E2D (R1) Guideline – post approval safety data: definitions and standards for management and reporting of individual case safety report All news

March 11, 2026

EU implementation strategy of ICH E2D (R1) Guideline – post approval safety data: definitions and standards for management and reporting of individual case safety report

The European Medicines Agency (EMA) has published the ICH E2D (R1) guidelines, which comes officially…

Saad

Love0

Understanding EudraVigilance All news

March 5, 2026

Understanding EudraVigilance

💊 What is EudraVigilance?   EudraVigilance is the European pharmacovigilance database 📊. It collects and…

Saad

Love0

A few key numbers All news

March 3, 2026

A few key numbers

Growth. Quality. Expertise. 🚀✨ Here’s a snapshot of our journey:

Saad

Love0

Rare Disease Day All news

February 27, 2026

Rare Disease Day

Rare Disease Day – 28 February 2026 🌍 Every year on 28 February, Rare Disease…

Saad

Love0

Final training module issued for ICH guideline E2B (R3) All news

February 24, 2026

Final training module issued for ICH guideline E2B (R3)

ICH has published Implementation Guide for Electronic Transmission of Individual Case Safety Reports (ICSRs), Module…

Saad

Love0

3 tips for understanding clinical trials All news

February 19, 2026

3 tips for understanding clinical trials

Saad

Love0

Entry into force of new European guidelines on marketing authorization fee All news

February 17, 2026

Entry into force of new European guidelines on marketing authorization fee

These new guidelines, which enter into force on 15 January 2026, entail a change in…

Saad

Love0

EMA and FDA set common principles for AI in medicine development All news

February 12, 2026

EMA and FDA set common principles for AI in medicine development

EMA and the U.S. Food and Drug Administration (FDA) have jointly identified ten principles to…

Saad

Love0

What is the role of a pharmacovigilance service provider? All news

February 10, 2026

What is the role of a pharmacovigilance service provider?

Saad

Love0

World Cancer Day All news

February 4, 2026

World Cancer Day

Saad

Love0

The Key Role of the QPPV in Europe 💊🛡️ All news

February 3, 2026

The Key Role of the QPPV in Europe 💊🛡️

Within the European regulatory framework, pharmacovigilance is essential to ensure patient safety. At the center…

Saad

Love0

Good pharmacovigilance practices All news

January 26, 2026

Good pharmacovigilance practices

The ANSM’s FAQ on Good Pharmacovigilance Practices has recently been updated. This revision introduces several…

Saad

Love0

Pharmacovigilance in Clinical Trials 🧪💊 All news

January 6, 2026

Pharmacovigilance in Clinical Trials 🧪💊

Pharmacovigilance plays a critical role throughout the life cycle of a medicinal product, and clinical trials…

Saad

Love0

Pharmya wish you a merry Christmas and a happy new year ! All news

December 24, 2025

Pharmya wish you a merry Christmas and a happy new year !

Saad

Love0

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 December 2025 All news

December 15, 2025

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 8-11 December 2025

Seven new medicines recommended for approval; another 12 medicines recommended for extension of their therapeutic…

Saad

Love0

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 24 – 27 November 2025 All news

December 4, 2025

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 24 – 27 November 2025

At its monthly meeting, EMA’s safety committee (PRAC) carried out its broad range of responsibilities,…

Saad

Love0